Search
Menu
Home
HTB
2005
June
HTB
June 2005
Contents
Editorial
Volume 6 Number 6 June 2005
Conference reports
11th BHIVA and BASSH joint annual conference, 22-25 April 2005, Dublin
Long-awaited UK pregnancy guidelines now updated; pregnancy studies in Dublin
Underdosing of ARVs in children: results from CHIPS cohort
Sexual transmission and response to treatment in acute HCV infection in HIV-positive gay men coinfected with HIV
Levels of efavirenz 10-fold above minimum target level despite coadministration with rifampicin
Schistosomiasis after immune reconstitution: symptoms appear as HAART side effects
6th International Workshop on Clinical Pharmacology of HIV Therapy, 28-30 April 2005, Quebec, Canada
Effect of age/menopause on lopinavir and efavirenz concentrations in women
Effect of age on lopinavir concentrations
Gender and pharmacokinetics of saquinavir
Dosing nevirapine in children
Intracellular NRTI-triphosphate levels in children are similar to adults
Efavirenz and rifampicin: lower body weight associated with higher concentrations
Summary of drug-drug interaction studies
Responses to atazanavir, Kaletra and side effects
Antiretrovirals
500mg saquinavir (Invirase) approved in Europe
Roche to withdraw saquinavir soft gel caps (Fortovase)
FDA approve lopinavir/r once daily for treatment naive patients
Safety data for tenofovir updated
FDA approve entecavir for HBV
Efavirenz warning in pregnancy strengthened
New ritonavir interactions
FDA advisory committee recommends approval for tipranavir – material from hearing online
Application for meltrex formulation of Kaletra submitted to the FDA
Treatment access
MSF criticises Brazilian government for failing to break antiretroviral patents
Russian activists imprisoned for asking for treatment – letters of support requested
Guidelines
US adult treatment guidelines updated (2005)
On the web
TAC electronic newsletter
Articles from AIDS Treatment News
AIDS Vaccine Advocacy Coalition (AVAC) publishes new AIDS Vaccine Handbook
WHO lists reliable web sites on vaccines
PDFs
Volume 6 Number 6 June 2005 PDF
HTB RSS
Early access
Lenacapavir submitted to the US FDA with an indication for HIV PrEP
20 December 2024
i-Base guides updated online
5 December 2024
All early access reports
Current issues
December 2024
November 2024
October 2024
Back issues
Special report
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate